QNRX
Quoin Pharmaceuticals, Ltd. American Depositary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Quoin Pharmaceuticals (QNRX) Stock: Buy, Sell, or Hold?
$3.76
+0.03 (+0.80%)
▲
5d:
-6.47%
30d:
-9.4%
90d:
-37.85%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
48/100
Position
OVERSOLD
30-Day Fair Range
$3.83 – $4.40
Position: OVERSOLD
Forward P/E & Valuation
-1.4x
Next 12M consensus est.
Wall Street Target
$20.38
+441.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.45 / $4.62
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: QNRX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When QNRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: QNRX is currently trading at $3.76, which is considered oversold relative to its 30-day fair value range of $3.83 to $4.40.
Technical Outlook: Technically, QNRX is showing sideways momentum. Immediate support is located at $3.45, while resistance sits at $4.62.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.38 (+441.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QNRX is showing sideways momentum. Immediate support is located at $3.45, while resistance sits at $4.62.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.38 (+441.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.83 -
$4.40
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$3.83 -
$4.40
Current vs Trading Range
OVERSOLD
Support Level
$3.45
Resistance Level
$4.62
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 441.9% below Wall St target ($20.38)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.39
Wall Street Target
$20.38
(+441.9%)
Share QNRX Analysis
Share this live QNRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
Data refreshes hourly during market hours. Next update: 8:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 45 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive QNRX Research Pages
